BNF for Children April 2024 Update

This update contains 4 significant changes, 2 new monographs, 1 new preparation, 1 deleted monograph and 1 deleted preparation.

Significant Changes:

• Ceftriaxone: update to structure of indications and dose section.
• Clindamycin: update to structure of indications and dose section.
• Contraceptives, non-hormonal: updated guidance in-line with Faculty of Sexual & Reproductive Healthcare recommendations on intra-uterine contraception.
• Valproate (Belvo®, Convulex®, Depakote®, Dyzantil®, Epilim®, Epilim Chrono® or Chronosphere®, Episenta®, Epival®, and Syonell®): new safety and educational materials to support regulatory measures in men and women under 55 years of age [MHRA/CHM advice] (advice in sodium valproate, valproic acid; see example in sodium valproate).

New Monographs:

• Ebglyss® [lebrikizumab].
• Kanuma® [sebelipase alfa].

New Preparations: Etacortilen® eye drops [dexamethasone].

Deleted Monographs: Benzoin tincture, compound.

Deleted Preparations: Hibitane® Plus 5% concentrate solution [chlorhexidine].